Imodium and Azactam drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Imodium (loperamide hydrochloride) and Azactam (aztreonam). Common drug interactions include hypomagnesaemia among females and apnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Imodium and Azactam. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Imodium?

Imodium has active ingredients of loperamide hydrochloride. It is often used in diarrhea. eHealthMe is studying from 45,092 Imodium users. Check the latest studies of Imodium.

What is Azactam?

Azactam has active ingredients of aztreonam. eHealthMe is studying from 1,044 Azactam users. Check the latest studies of Azactam.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 03, 2026

11 people who take Imodium and Azactam together, and have interactions are studied.

Imodium and Azactam drug interactions.

What are the common drug interactions of Imodium and Azactam, by gender? *:

female:

  1. Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
  2. Torsade de pointes (a abnormal heart rate with abnormal beating pattern)
  3. Ventricular fibrillation (abnormally irregular heart rhythm)
  4. Hepatobiliary disease (diseases affect the liver and/or biliary tract)
  5. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  6. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  7. Neutropenia (an abnormally low number of neutrophils)
  8. Colitis (inflammation of colon)
  9. Rash

male:

  1. Apnoea (suspension of external breathing)
  2. Blood creatinine increased
  3. Urinary retention (the inability to completely or partially empty the bladder)
  4. Blood urea increased
  5. Cardiac disorder
  6. Dysphagia (a condition in which swallowing is difficult or painful)
  7. Generalised oedema (swelling all over the body)
  8. Neutropenia (an abnormally low number of neutrophils)
  9. Pulse absent
  10. Pyrexia (fever)

What are the common drug interactions of Imodium and Azactam, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Hepatobiliary disease (diseases affect the liver and/or biliary tract)

30-39:

n/a

40-49:

n/a

50-59:

  1. Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
  2. Torsade de pointes (a abnormal heart rate with abnormal beating pattern)
  3. Ventricular fibrillation (abnormally irregular heart rhythm)

60+:

  1. Neutropenia (an abnormally low number of neutrophils)
  2. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  3. Pulse absent
  4. Pyrexia (fever)
  5. Sudden death
  6. Urinary retention (the inability to completely or partially empty the bladder)
  7. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  8. Apnoea (suspension of external breathing)
  9. Blood creatinine increased
  10. Blood urea increased

What are the existing conditions these people have? *

  1. Constipation: 4 people, 36.36%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 36.36%
  3. Nausea (feeling of having an urge to vomit): 4 people, 36.36%
  4. Fever: 4 people, 36.36%
  5. White Blood Cell Disorder: 2 people, 18.18%
  6. Febrile Neutropenia (fever with reduced white blood cells): 2 people, 18.18%
  7. Hyperglycemia (high blood sugar): 2 people, 18.18%
  8. Human Herpesvirus 6 Infection: 2 people, 18.18%
  9. High Blood Pressure: 2 people, 18.18%
  10. Herpes Simplex (herpes simplex is a common viral infection): 2 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take Imodium and Azactam?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Imodium and Azactam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Imodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Azactam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Imodium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Azactam and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on loperamide hydrochloride and aztreonam (the active ingredients of Imodium and Azactam, respectively), and Imodium and Azactam (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: